| 0 |
Interleukin-6 Antagonist [EPC] |
1 |
0.0015 |
| 1 |
Programmed Death Ligand-1 Blocker [EPC] |
7 |
0.0003 |
| 2 |
Carnitine Analog [EPC] |
1 |
0.0003 |
| 3 |
CTLA-4-directed Blocking Antibody [EPC] |
8 |
0.0002 |
| 4 |
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] |
1 |
0.0002 |
| 5 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
7 |
0.0001 |
| 6 |
Microtubule Inhibitor [EPC] |
9 |
0.0001 |
| 7 |
Orexin Receptor Antagonist [EPC] |
1 |
0.0001 |
| 8 |
Typical Antipsychotic [EPC] |
1 |
0.0000 |
| 9 |
Platinum-based Drug [EPC] |
10 |
0.0000 |
| 10 |
Penem Antibacterial [EPC] |
1 |
0.0000 |
| 11 |
Glycopeptide Antibacterial [EPC] |
1 |
0.0000 |
| 12 |
Tetracycline-class Drug [EPC] |
1 |
0.0000 |
| 13 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
1 |
0.0000 |
| 14 |
5-alpha Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 15 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
1 |
0.0000 |
| 16 |
Fluoroquinolone Antibacterial [EPC] |
1 |
0.0000 |
| 17 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 18 |
Nucleoside Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 19 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 20 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 21 |
Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 22 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 23 |
Vitamin C [EPC] |
1 |
0.0000 |
| 24 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 25 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |
| 26 |
Benzodiazepine [EPC] |
1 |
0.0000 |
| 27 |
Corticosteroid [EPC] |
1 |
0.0000 |
| 28 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
1 |
0.0000 |